Início/Ações/OMER

OMER

USD

Omeros Corporation Common Stock

$6.730-0.330 (-4.674%)

Preço em tempo real

Healthcare

Biotecnologia

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$7.060

Máximo

$7.240

Mínimo

$6.710

Volume

1.29M

Fundamentos da empresa

Capitalização de mercado

458.0M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

3.30M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $2.95Atual $6.730Máximo $13.6

Notícias relacionadas

15/10/2025 · 12:34

Reuters

Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push

Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 billion for the U.S.-based company's experimental drug, which is being developed for rare blood and kidney disorders, they said on Wednesday.

Ver mais

Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push

15/10/2025 · 12:30

GlobeNewswire

Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros' clinical-stage MASP-3 inhibitor zaltenibart (OMS906)

Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk's Rare Disease portfolioOmeros is eligible to receive 340 million US dollars in upfront and near-term

Ver mais